Free Trial
Anne Samuel

Anne Samuel Analyst Performance

Executive Director, U.S. Healthcare Technology & Distribution at JPMorgan Chase & Co.

Anne Samuel is a stock analyst at JPMorgan Chase & Co. focused in the medical sector, covering 7 publicly traded companies. Over the past year, Anne Samuel has issued 6 stock ratings, including buy and hold recommendations. While full access to Anne Samuel's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anne Samuel's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 1 Years
Buy Recommendations
50.00% 6 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%6 ratings
Hold50.0%6 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Anne Samuel at JPMorgan Chase & Co., the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
57.1% of companies on NYSE
4 companies
NASDAQ
42.9% of companies on NASDAQ
3 companies

Anne Samuel, an analyst at JPMorgan Chase & Co., currently covers 7 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
71.4%
Computer and Technology
1 company
14.3%
Services
1 company
14.3%

Anne Samuel of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Services companies.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
2 companies
28.6%
MEDICAL INFO SYS
2 companies
28.6%
INTERNET SOFTWARE
1 company
14.3%
SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING
1 company
14.3%
MED INSTRUMENTS
1 company
14.3%

Anne Samuel's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Evolent Health, Inc stock logo
EVH
Evolent Health
11/17/2025Lower Price Target$4.00$7.00Overweight
HealthEquity, Inc. stock logo
HQY
HealthEquity
9/3/2025Boost Price Target$92.88$126.00Overweight
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
8/28/2025Boost Price Target$272.51$290.00Neutral
Progyny, Inc. stock logo
PGNY
Progyny
8/26/2025Boost Price Target$22.80$25.00Neutral
Doximity, Inc. stock logo
DOCS
Doximity
5/27/2025Lower Price Target$51.95$60.00Neutral
IQVIA Holdings Inc. stock logo
IQV
IQVIA
5/19/2025Lower Price Target$141.15$177.00Overweight
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
3/20/2025Boost Price Target$236.47$249.00Neutral
Omnicell, Inc. stock logo
OMCL
Omnicell
3/20/2025Lower Price Target$34.97$36.00Neutral
Evolent Health, Inc stock logo
EVH
Evolent Health
3/10/2025Lower Price Target$9.26$12.00Overweight
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2/18/2025Lower Price Target$195.78$232.00Overweight
Evolent Health, Inc stock logo
EVH
Evolent Health
1/28/2025Lower Price Target$10.20$13.00Overweight
Progyny, Inc. stock logo
PGNY
Progyny
1/28/2025Boost Price Target$23.62$23.00Neutral